Advanced Search
Contact | Corporate | Help

A Study of Bevacizumab to Prevent Malignant Ascites

Sponsors:
  • Baylor College of Medicine
  • Genentech
Phases:
  • Phase II
IndicationsAcronym:
  • Malignant Ascites
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: Bevacizumab
Enrollment:
20

Additional information about NCT00908219.


SourceSolution © 2008-2012